Product Categories
| Country: | United States |
|---|---|
| Tel: | 552-7181 |
| E-mail: | sales@aladdinsci.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 14078 Meridian Parkway, Riverside |
|
Aladdin Scientific Corporation is a listed company on the A-share Science and Technology Board (stock code: 688179), which has been deeply engaging in the field of scientific research reagents for more than ten years, and is a manufacturer of scientific research reagents integrating research and development, production and sales. After years of exploration, accumulation and development, it owns six major product lines of chemistry and biochemistry reagents, material sciences, drug-targeting ligands, proteins, antibodies, and I-Quip?? labware. Product line.
Relying on its own e-commerce platform (www.aladdinsci.com), Aladdin provides a huge product line covering hundreds of thousands of scientific research reagents and thousands of consumables/instruments, which are widely used in colleges and universities, scientific research institutes, medical treatment, medicine, pharmaceuticals, diagnostics, new materials, new energy, energy conservation and environmental protection, aerospace and other high-tech industries as well as their upstream and downstream enterprises. Corporation
|
|
| Product Name | MF | CAS | Details |
|---|
| Okanin | C15H12O6 | 484-76-4 | Details |
| 3-O-Methyldopa-d3 | C10H13NO4 | 586954-09-8 | Details |
| 3-[tert-butyl(diphenyl)silyl]oxy-2,2-dimethyl-propanoic acid | C21H28O3Si | 480450-04-2 | Details |
| Orexin 2 Receptor Agonist | C32H34N4O5S | 1796565-52-0 | Details |
| Olcegepant hydrochloride | C38H48Br2ClN9O5 | 586368-06-1 | Details |
| Oleic acid-d2 | C18H32D2O2 | 5711-29-5 | Details |
| Oseltamivir-acetate | C18H30N2O5 | 1191921-01-3 | Details |
| Odronextamab | 1801338-64-6 | Details |
| Orexin receptor antagonist 3 | C21H22N8O3 | 1293282-55-9 | Details |
| 4-oxo-3,4-dihydrophthalazine-1-carboxylic acid | C9H6N2O3 | 3260-44-4 | Details |
| OVA-E1 peptide TFA | C49H77F3N10O16 | 1262750-80-0 | Details |
| 3-oxa-8-azabicyclo[3.2.1]octan-1-ylmethanol;hydrochloride | C7H13NO2.ClH | 2643374-51-8 | Details |
| 2-[tert-butyl(dimethyl)silyl]oxy-2-(5-fluoro-2-pyridyl)ethanol | C13H22FNO2Si | 2816913-53-6 | Details |
| Olmesartan-d4 | C24H22N6O3D4 | 1420880-41-6 | Details |
| 2'-O-Methylisoliquiritigenin | C16H14O4 | 51828-10-5 | Details |
| OPC-14523 hydrochloride | C23H29Cl2N3O2 | 145969-31-9 | Details |
| Org-26576 | C11H12N2O2 | 100044-96-0 | Details |
| Olumacostat glasaretil | C26H43NO7 | 1261491-89-7 | Details |
| ODN 1668 | 1186063-66-0 | Details |
| ODM-207 | C22H21N3O3 | 1801503-93-4 | Details |
| Omapatrilat | C19H24N2O4S2 | 167305-00-2 | Details |
| OM-153 | C28H24FN7O2 | 2406278-81-5 | Details |
| O6-tert-butyl O7-methyl 2,2-difluoro-6-azaspiro[3.4]octane-6,7-dicarboxylate | C14H21F2NO4 | 2797494-25-6 | Details |
| ODN 2395 | 1254617-22-5 | Details |
| Oroxylin A-7-O-glucuronide | C22H20O11 | 36948-76-2 | Details |
| Omeprazole-d3-1 | C17H16D3N3O3S | 934293-92-2 | Details |
| ONO-0300302 | C29H35NO5 | 856689-51-5 | Details |
| OF-C4-Deg-Lin | C100H176N4O10 | 2383003-60-7 | Details |
| ODN 1018 | 937402-51-2 | Details |
| ODN 2007 | 455348-63-7 | Details |
| 5'-O-DMT-N4-Bz-5-Me-dC | C38H37N3O7 | 104579-03-5 | Details |
| Obtusin | C18H16O7 | 70588-05-5 | Details |
| Odiparcil | C15H16O6S | 137215-12-4 | Details |
| ORM-15341 | C19H17ClN6O2 | 1297537-33-7 | Details |
| Omadacycline hydrochloride | C29H41ClN4O7 | 1196800-39-1 | Details |
| Osilodrostat phosphate | C13H13FN3O4P | 1315449-72-9 | Details |
| Oxyphyllacinol | C20H26O3 | 87657-77-0 | Details |
| Omiganan | C90H127N27O12 | 204248-78-2 | Details |
| Olaparib-d5 | C24H23FN4O3 | 2143107-56-4 | Details |
| OVA Peptide (323-339) | C74H120N26O25 | 92915-79-2 | Details |
| Omidenepag isopropyl | C26H28N6O4S | 1187451-19-9 | Details |
| 5'-O-TBDMS-dA | C16H27N5O3Si | 51549-30-5 | Details |
| 306Oi10 | C59H115N3O8 | 2322290-93-5 | Details |
| OTS447 | C27H32ClN3O2 | 1356943-67-3 | Details |
| Oritavancin diphosphate | C86H103Cl3N10O34P2 | 192564-14-0 | Details |
| OTSSP167 hydrochloride | C25H29Cl3N4O2 | 1431698-10-0 | Details |
| ON-013100 | C19H22O7S | 865783-95-5 | Details |
| OXFBD04 | C17H16N2O3 | 2231747-03-6 | Details |
| 6-O-Propynyl-2'-deoxyguanosine | C13H15N5O4 | 1640051-47-3 | Details |
| α-Obscurine | C17H26N2O | 596-55-4 | Details |
| OT-R antagonist 1 | C28H29N3O4 | 364071-17-0 | Details |
| 2-O-Acetyl-20-hydroxyecdysone | C29H46O8 | 19536-25-5 | Details |
| Oxotremorine M iodide | C11H19IN2O | 3854-04-4 | Details |
| OTS193320 | C28H30ClN5O4 | 2093401-33-1 | Details |
| ORIC-101 | C34H47NO2 | 2222344-98-9 | Details |
| ODN 2216 | 332437-00-0 | Details |
| 4-O-Methyl honokiol | C19H20O2 | 68592-15-4 | Details |
| Onjisaponin B | C75H112O35 | 35906-36-6 | Details |
| Oxyresveratrol 2-O-β-D-glucopyranoside | C20H22O9 | 392274-22-5 | Details |
| Oxytocin parallel dimer | C86H132N24O24S4 | 19645-28-4 | Details |
| Oteseconazole | C23H16F7N5O2 | 1340593-59-0 | Details |
| (Thr4,Gly7)-Oxytocin | C39H61N11O12S2 | 60786-59-6 | Details |
| Opiranserin hydrochloride | C21H34N2O5.ClH | 1440796-75-7 | Details |
| Osimertinib-d6 | C28H33N7O2 | 1638281-44-3 | Details |
| Obeldesivir | C16H19N5O5 | 2647441-36-7 | Details |
| 18-Oxocortisol | C21H28O6 | 2410-60-8 | Details |
| 4'-O-Methylbavachalcone | C21H22O4 | 20784-60-5 | Details |
| 4-oxocyclohexane-1,1-dicarboxylic acid | C8H10O5 | 58230-12-9 | Details |
| O1-benzyl O3-methyl (3S)-piperidine-1,3-dicarboxylate | C15H19NO4 | 88466-73-3 | Details |
| O-Desmethyl Mebeverine alcohol hydrochloride | C15H26ClNO2 | 856620-39-8 | Details |
| Osteogenic Growth Peptide (10-14) | C24H29N5O7 | 105250-85-9 | Details |
| Olacaftor | C29H34FN3O4S | 1897384-89-2 | Details |
| Org41841 | C19H22N4O2S2 | 301847-37-0 | Details |
| OVA Peptide(257-264) TFA | C47H75F3N10O15 | 1262751-08-5 | Details |
| ONO-8430506 | C27H28FN3O3 | 1354805-08-5 | Details |
| Oritinib | C31H37N7O2 | 2035089-28-0 | Details |
| ODN 24991 | 1682661-49-9 | Details |
| ODN 1826 | 202668-42-6 | Details |
| OT-R antagonist 2 | C28H29N3O4 | 364071-16-9 | Details |
| OSIP-486823 | C29H28FNO4 | 200803-37-8 | Details |
| Orotidine 5′-monophosphate trisodium | C10H10N2Na3O11P | 68244-58-6 | Details |
| 1-(iodomethyl)-7-oxabicyclo[2.2.1]heptane | C7H11IO | 946402-76-2 | Details |
| ODN 1585 | 386832-46-8 | Details |
| ONO-0740556 | C20H34NO6P | 2250210-69-4 | Details |
| O3-benzyl O1-tert-butyl 4,4-dimethylpyrrolidine-1,3-dicarboxylate | C19H27NO4 | 2816914-17-5 | Details |
| (S)-Osanetant | 182621-58-5 | Details |
| (2R)-Octyl-α-hydroxyglutarate | C13H24O5 | 1391194-67-4 | Details |
| Oglufanide | C16H19N3O5 | 38101-59-6 | Details |
| Odapipam | C19H20ClNO2 | 131796-63-9 | Details |
| ODN D-SL03 | 1198621-85-0 | Details |
| ODN 2336 | 332956-64-6 | Details |
| O6-tert-butyl O8-ethyl 2-hydroxy-6-azaspiro[3.4]octane-6,8-dicarboxylate | C15H25NO5 | 2865115-28-0 | Details |
| Orexin 2 Receptor Agonist 2 | C23H33FN2O4S | 2114324-60-4 | Details |
| (R)-Olacaftor | C29H34FN3O4S | 1899111-41-1 | Details |
| ORM-10962 | C27H29N3O4 | 763926-98-3 | Details |
| 4-oxo-3-azaspiro[5.5]undecane-11-carboxylic acid;hydrochloride | C11H17NO3.ClH | 2740387-42-0 | Details |
| ODN 20844 | 1964506-29-3 | Details |
| [Asp5]-Oxytocin | C43H65N11O13S2 | 65907-78-0 | Details |
| 6-oxo-3-azabicyclo[3.2.0]heptane-2-carboxylic acid;2,2,2-trifluoroacetic acid | C7H9NO3.C2HF3O2 | 2821030-52-6 | Details |
| Oxyntomodulin | C192H295N59O60S | 62340-29-8 | Details |
| Product Total： Product Page： | ||||
| 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 | ||||